Article Details
Retrieved on: 2021-06-20 23:26:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Umoja Biopharma, a Seattle, WA-based oncology company, closed a $210m Series B financing. The round was co-led by SoftBank Vision Fund 2 and ...
Article found on: www.finsmes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here